Preoperative concurrent chemotherapy with accelerated hyperfractionated radiotherapy in non-small-cell lung cancer;: feasibility, toxicity and long-term results of a phase II study

被引：0
|
作者：
Casas, F.
Vinolas, N.
Marruecos, J.
Carcereny, E.
Jorcano, S.
Gimferrer, J. M.
Marrades, R.
Luburich, P.
Agusti, C.
机构：
[1] Hosp Clin Barcelona, Radiat Oncol ICMHO, Barcelona, Spain
[2] Hosp Clin Barcelona, Lung Canc Comm, Barcelona, Spain
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：328 / 328
页数：1
相关论文
共 50 条
  • [1] Preoperative concurrent chemoradiotherapy in non-small-cell lung cancer.: Feasibility, toxicity and long-term results of a phase II study
    Viñolas, N
    Casas, F
    Belda, J
    Reguart, N
    Carcereny, E
    Gimferrer, J
    Marrades, R
    Jorcano, S
    Marmol, M
    Ramirez, J
    LUNG CANCER, 2005, 49 : S175 - S175
  • [2] Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer:: Mature results of a phase II trial
    Eberhardt, W
    Wilke, H
    Stamatis, G
    Stuschke, M
    Harstrick, A
    Menker, H
    Krause, B
    Müeller, MR
    Stahl, M
    Flasshove, M
    Budach, V
    Greschuchna, D
    Konietzko, N
    Sack, H
    Seeber, S
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) : 622 - 634
  • [3] Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin and paclitaxel in patients with stage III non-small-cell lung cancer: Long-term results of a phase II study
    Jeremic, B
    Milicic, B
    Acimovic, L
    Milisavljevic, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) : 1144 - 1151
  • [4] A phase II study of concurrent accelerated hyperfractionated radiotherapy and carboplatin/oral etoposide for elderly patients with stage III non-small-cell lung cancer
    Jeremic, B
    Shibamoto, Y
    Milicic, B
    Milisavljevic, S
    Nikolic, N
    Dagovic, A
    Aleksandrovic, J
    Radosavljevic-Asic, G
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (02): : 343 - 348
  • [5] A phase II trial of induction chemotherapy followed by continuous hyperfractionated accelerated radiotherapy in locally advanced non-small-cell lung cancer
    Jenkins, Peter
    Anderson, Susan
    Wronski, Susan
    Ashton, Anita
    RADIOTHERAPY AND ONCOLOGY, 2009, 93 (03) : 396 - 401
  • [6] Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin/paclitaxel in patients with early-stage (I/II) non-small-cell lung cancer: Long-term results of a phase II study
    Jeremic, B
    Milicic, B
    Acimovic, L
    Milisavljevic, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) : 6873 - 6880
  • [7] Five-year results of a phase II trial of hyperfractionated radiotherapy and concurrent daily cisplatin chemotherapy for stage III non-small-cell lung cancer
    Keene, KS
    Harman, EM
    Knauf, DG
    McCarley, D
    Zlotecki, RA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (03): : 217 - 222
  • [8] Concurrent radiochemotherapy for patients with stage III non-small-cell lung cancer (NSCLC): Long-term results of a phase II study
    Jeremic, B
    Shibamoto, Y
    Milicic, B
    Nikolic, N
    Dagovic, A
    Milisavljevic, S
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (05): : 1091 - 1096
  • [9] ACCELERATED HYPOFRACTIONATED RADIOTHERAPY FOR EARLY-STAGE NON-SMALL-CELL LUNG CANCER: LONG-TERM RESULTS
    Soliman, Hany
    Cheung, Patrick
    Yeung, Latifa
    Poon, Ian
    Balogh, Judith
    Barbera, Lisa
    Spayne, Jacqueline
    Danjoux, Cyril
    Dahele, Max
    Ung, Yee
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (02): : 459 - 465
  • [10] Long term results of concurrent accelerated hypofractionated radiotherapy and chemotherapy with cisplatinum ± vinorelbine in non-small cell lung cancer
    Maguire, Joseph
    Kelly, Veronica
    Page, Richard
    Ledson, Martin
    Smyth, Colin
    Walshaw, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S951 - S951
12345